TVTX earnings: a positive outcome, +8.1%

On November 7, 2023, Travere Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.1% in the window around the event. It had already run -8.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.